INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Why Biotech CRO Partnerships Are Essential For Clinical Trial Success
For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.
-
In-Vivo CAR Therapies — Global Research And Development Landscape
Delve into the evolving in-vivo CAR therapy landscape, examining key technological innovations, major industry players, recent clinical progress, and regulatory developments.
-
Why Flexible Payment Options Matter For Clinical Trial Participants
In clinical trials, offering a variety of payment options is critical for participant retention and overall study success. How can you make the payment process simple and flexible?
-
AI-Powered Strategy Is Redefining Patient Recruitment Performance
This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover6/7/2024
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Reducing Time To First-In-Human Trials With Robotic SFF Services6/21/2024
Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.
-
The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up9/3/2025
Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.
-
Tips And Tricks For Developing Rare Cancer Clinical Trials2/6/2025
Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
-
Clinical Trials In The Age Of Cost Caps4/14/2025
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
What services are available to help you ensure continuous functional coverage, enhancing business continuity, operational efficiency, and risk mitigation?
-
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
Experience the difference that dedicated, top-tier professionals can make in achieving excellence and innovative solutions in clinical outsourcing.
-
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.